Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

Palella, 1998, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection, N Engl J Med, 338, 853, 10.1056/NEJM199803263381301 2000, Survival after introduction of HAART in people with known duration of HIV-1 infection, Lancet, 355, 1158, 10.1016/S0140-6736(00)02069-9 Sherman, 1991, Prevalence of antibodies to hepatitis C virus in patients infected with the human immunodeficiency virus, J Infect Dis, 163, 414, 10.1093/infdis/163.2.414 Salmon-Céron, 2003, Hospitalized HIV-HCV co-infected patients. A French national survey made in June 2001, Med Mal Infect, 33, 78, 10.1016/S0399-077X(03)00022-2 Saillour, 1996, Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine, Br Med J, 313, 461, 10.1136/bmj.313.7055.461 Hayashi, 1991, Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus, J Med Virol, 33, 177, 10.1002/jmv.1890330307 Thio, 2002, HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter AIDS cohort study (MACS), Lancet, 360, 1921, 10.1016/S0140-6736(02)11913-1 Cribier, 1995, High hepatitis viremia and impaired antibody response in patients co-infected with HIV, AIDS, 9, 1131, 10.1097/00002030-199510000-00003 Soto, 1997, Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis, J Hepatol, 26, 1, 10.1016/S0168-8278(97)80001-3 Benhamou, 1999, Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients, Hepatology, 30, 1054, 10.1002/hep.510300409 Puoti, 2000, Mortality from liver disease in patients with HIV infection: a cohort study, J Acquir Immune Defic Syndr, 24, 211, 10.1097/00042560-200007010-00003 Darby, 1997, Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C, Lancet, 350, 1425, 10.1016/S0140-6736(97)05413-5 Monga, 2001, Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection, Clin Infect Dis, 33, 240, 10.1086/321819 Conti, 2002, Excess mortality from liver disease and other non-AIDS-related diseases among HIV-infected individuals in Italy, J Acquir Immune Defic Syndr, 29, 105, 10.1097/00126334-200201010-00017 Rosenthal, 2003, Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 Study), AIDS, 17, 1, 10.1097/00002030-200308150-00009 Soriano, 2001, Mortality due to viral liver disease among patients infected with HIV, Clin Infect Dis, 32, 492, 10.1086/318501 Lewden C, Bévilacqua S, Bonnet F, Héripret L, Salmon D, Morlat P, et al. Causes of death in HIV-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol [in press]. International Classification of Diseases. Tenth Revision ed. Geneva: World Health Organization; 1993. Centers for Disease Control and Prevention, 1992, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR, 41, 1 El-Serag, 2002, Hepatocellular carcinoma and hepatitis C in the United States, Hepatology, 36, S74, 10.1002/hep.1840360710 Colombo, 2003, Etiology, natural history and treatment of hepatocellular carcinoma, Antiviral Res, 60, 145, 10.1016/j.antiviral.2003.08.010 Chung, 2004, Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons, N Engl J Med, 351, 451, 10.1056/NEJMoa032653 Carrat, 2004, Final Results of ANRS HC02 RIBAVIC: a randomized trial of pegylated-interferon alfa-2b plus ribavirin vs interferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-infected patients, J AM Med Assoc, 292, 2839, 10.1001/jama.292.23.2839 Torriani, 2004, Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients, N Engl J Med, 351, 438, 10.1056/NEJMoa040842 Manns, 2001, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial, Lancet, 358, 958, 10.1016/S0140-6736(01)06102-5 Alberti, 2005, Short statement of the First European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV Co-Infected patients, J Hepatol, 42, 615, 10.1016/j.jhep.2005.03.003